EVA HERNANDEZ: Open Payments
NPI 1487833372 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 21 payments from 13 companies in 2025. Trend: 2023 $1,428 · 2024 $2,727 · 2025 $577
Food & beverage: $482Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $133 |
| Amgen Inc. | 1 | $109 |
| PFIZER INC. | 1 | $61 |
| ABBVIE INC. | 3 | $54 |
| UCB, Inc. | 1 | $45 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $31 |
| GENZYME CORPORATION | 1 | $30 |
| Incyte Corporation | 1 | $23 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: TREMFYA, Otezla, CIBINQO, SKYRIZI, Bimzelx, DUPIXENT, OPZELURA, Cabtreo.
Industry payments across CA — which companies pay providers there.
